Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents Academic Article uri icon

Overview

MeSH Major

  • Immunosuppressive Agents
  • Inflammatory Bowel Diseases
  • Neoplasms

abstract

  • On the basis of a retrospective study, in patients with IBD and a history of cancer, exposure to an anti-TNF agent or an antimetabolite after cancer was not associated with an increased risk of incident cancer, compared with patients who did not receive immunosuppression. Larger, matched, prospective studies are needed to confirm these findings.

publication date

  • January 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.cgh.2015.07.037

PubMed ID

  • 26247164

Additional Document Info

start page

  • 58

end page

  • 64

volume

  • 14

number

  • 1